Anna Marie Wagner is Senior Vice President at Ginkgo Bioworks, where she also serves as Head of AI and Head of Corporate Development for the biotech company. In her roles, she oversees Ginkgo’s strategy, partnerships, and commercial execution in AI as well as Ginkgo’s capital markets and M&A functions. Wagner led Ginkgo’s partnership with Google Cloud in 2023 and Ginkgo’s public offering in 2021, raising over $1.6 billion for the company in what was the largest-ever public debut in biotech.

Ginkgo is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo’s biosecurity and public health unit, Concentric by Ginkgo, is building global infrastructure for biosecurity to empower governments, communities, and public health leaders to prevent, detect, and respond to a wide variety of biological threats. The company has partnerships with companies including Bayer, Biogen, Pfizer, Sumitomo, Novo Nordisk, Syngenta, Merck, and Corteva as well as with governments around the world.

Prior to joining Ginkgo Bioworks, Wagner was a technology investor at Bain Capital Private Equity. She holds a BA in Applied Mathematics and Economics from Harvard University and an MBA from Harvard Business School, where she was a Baker Scholar.

Fortune, Healthcare, Artificial Intelligence, Biotechnology, Biology Bioengineering, Research & Exploration, Science,